BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Demir Cetinkaya B, Biray Avci C. Molecular perspective on targeted therapy in breast cancer: a review of current status. Med Oncol 2022;39:149. [PMID: 35834030 DOI: 10.1007/s12032-022-01749-1] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
Number Citing Articles
1 Du X, Liu H, Tian Z, Zhang S, Shi L, Wang Y, Guo X, Zhang B, Yuan S, Zeng X, Zhang H. PI3K/AKT/mTOR pathway mediated-cell cycle dysregulation contribute to malignant proliferation of mouse spermatogonia induced by microcystin-leucine arginine. Environ Toxicol 2023;38:343-58. [PMID: 36288207 DOI: 10.1002/tox.23691] [Reference Citation Analysis]
2 Helal AA, Saad BT, Saad MT, Mosaad GS, Aboshanab KM. Evaluation of the Available Variant Calling Tools for Oxford Nanopore Sequencing in Breast Cancer. Genes (Basel) 2022;13:1583. [PMID: 36140751 DOI: 10.3390/genes13091583] [Reference Citation Analysis]
3 Grassilli S, Bertagnolo V, Brugnoli F. Mir-29b in Breast Cancer: A Promising Target for Therapeutic Approaches. Diagnostics 2022;12:2139. [DOI: 10.3390/diagnostics12092139] [Reference Citation Analysis]